These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 2899913)

  • 1. Rapid reversal of life-threatening hypoglycaemia with a somatostatin analogue (octreotide). A case report.
    Alberts AS; Falkson G
    S Afr Med J; 1988 Jul; 74(2):75-6. PubMed ID: 2899913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preoperative treatment of hypoglycemia caused by an insulinoma with the somatostatin analog SMS 201-995].
    Sánchez García Cervigón P; Fernández Navarro JI; Salmerón de Diego J; Caballero Asensi A; Cornelio Hernández F; Jara Albarrán A
    Med Clin (Barc); 1987 Oct; 89(12):511-3. PubMed ID: 2890800
    [No Abstract]   [Full Text] [Related]  

  • 3. On the use of a new somatostatin analogue in the treatment of hypoglycaemia in patients with insulinoma.
    Verschoor L; Uitterlinden P; Lamberts SW; Del Pozo E
    Clin Endocrinol (Oxf); 1986 Nov; 25(5):555-60. PubMed ID: 2887309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of insulinoma with the somatostatin analog SMS 201-995].
    Gilsanz Peral A; Gómez Balaguer M; Costa Talens P
    Med Clin (Barc); 1988 Apr; 90(15):634-5. PubMed ID: 2899658
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic treatment of a benign insulinoma using the long-acting somatostatin analogue SMS 201-995.
    Glaser B; Rösler A; Halperin Y
    Isr J Med Sci; 1990 Jan; 26(1):16-9. PubMed ID: 2155884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of hypoglycaemia in a patient with pancreatic microadenomatosis by a long-acting somatostatin analogue SMS 201-995.
    Kung AW; Ma JT; Wang C; Fu KH; Lam KS; Yeung RT; Boey J
    Clin Endocrinol (Oxf); 1987 Oct; 27(4):469-73. PubMed ID: 2893673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycaemia due to insulinoma.
    Ramani A; Kundaje GN; Nayak MN
    J Assoc Physicians India; 1990 Feb; 38(2):175-6. PubMed ID: 2166025
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment: symptomatic treatment of hypoglycaemia.
    Tabarin A; Goichot B;
    Ann Endocrinol (Paris); 2013 Jul; 74(3):196-9. PubMed ID: 23791453
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypoglycemia caused by insulinoma in diabetes mellitus].
    Heik SC; Klöppel G; Krone W; Iben G; Priebe K; Kühnau J
    Dtsch Med Wochenschr; 1988 Nov; 113(44):1714-7. PubMed ID: 2846254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera.
    Maton PN; O'Dorisio TM; Howe BA; McArthur KE; Howard JM; Cherner JA; Malarkey TB; Collen MJ; Gardner JD; Jensen RT
    N Engl J Med; 1985 Jan; 312(1):17-21. PubMed ID: 2856888
    [No Abstract]   [Full Text] [Related]  

  • 11. Somatostatin analogs in the management of gastrointestinal tumors.
    Lamberts SW
    Horm Res; 1988; 29(2-3):118-20. PubMed ID: 2900191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant insulinoma.
    Teh LB; Rauff A; Lee CN
    Singapore Med J; 1982 Feb; 23(1):39-41. PubMed ID: 6287647
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypoglycemia--a report on 5 patients with insulinoma and 1 with pleural mesothelioma].
    Renar IP; Granić M; Sucić M; Milicević Z; Stulhofer M; Skrabalo Z
    Lijec Vjesn; 1986 May; 108(5):182-5. PubMed ID: 3014241
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved control of severe hypoglycemia in patients with malignant insulinomas by peptide receptor radionuclide therapy.
    van Schaik E; van Vliet EI; Feelders RA; Krenning EP; Khan S; Kamp K; Valkema R; van Nederveen FH; Teunissen JJ; Kwekkeboom DJ; de Herder WW
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3381-9. PubMed ID: 21917872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995).
    Kvols LK; Buck M; Moertel CG; Schutt AJ; Rubin J; O'Connell MJ; Hahn RG
    Ann Intern Med; 1987 Aug; 107(2):162-8. PubMed ID: 2886085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pasireotide for malignant insulinoma.
    Tirosh A; Stemmer SM; Solomonov E; Elnekave E; Saeger W; Ravkin Y; Nir K; Talmor Y; Shimon I
    Hormones (Athens); 2016 Apr; 15(2):271-276. PubMed ID: 26732164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant insulinoma: is combined treatment with verapamil and the long-acting somatostatin analogue octreotide (SMS 201-995) more effective than single therapy with either drug?
    Stehouwer CD; Lems WF; Fischer HR; Hackeng WH
    Neth J Med; 1989 Aug; 35(1-2):86-94. PubMed ID: 2550827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mithramycin for hypoglycemia in malignant insulinoma.
    Kiang DT; Frenning DH; Bauer GE
    N Engl J Med; 1978 Jul; 299(3):134-5. PubMed ID: 207984
    [No Abstract]   [Full Text] [Related]  

  • 19. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
    Vezzosi D; Bennet A; Rochaix P; Courbon F; Selves J; Pradere B; Buscail L; Susini C; Caron P
    Eur J Endocrinol; 2005 May; 152(5):757-67. PubMed ID: 15879362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycemia due to insulinoma. An unusual cause of altered mental status in a young man.
    Powers RD; Robb JF
    Minn Med; 1983 Jan; 66(1):13-5. PubMed ID: 6302465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.